Chang CY, Li TY, Cheng SN, Pan RY, Wang HJ, Lin SY, Chen YC Prevalence and severity by age and other clinical correlates of haemophilic arthropathy of the elbow, knee and ankle among Taiwanese patients with haemophilia. Haemophilia. 2017 Mar;23(2):284-291. doi: 10.1111/hae.13117. Epub 2016 Nov 8.
Groen WG, den Uijl IE, van der Net J, Grobbee DE, de Groot PG, Fischer K Protected by nature? Effects of strenuous physical exercise on FVIII activity in moderate and mild haemophilia A patients: a pilot study. Haemophilia. 2013 Jul;19(4):519-23. doi: 10.1111/hae.12111. Epub 2013 Mar 19.
Lafeber FP, Miossec P, Valentino LA Physiopathology of haemophilic arthropathy. Haemophilia. 2008 Jul;14 Suppl 4:3-9. doi: 10.1111/j.1365-2516.2008.01732.x. Review.
Lalezari S, Martinowitz U, Windyga J, Enriquez MM, Delesen H, Schwartz L, Scharrer I Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS. Haemophilia. 2014 Jan;20(1):e15-22. doi: 10.1111/hae.12294. Epub 2013 Nov 20. Erratum in: Haemophilia. 2014 Mar;20(2):e193.
Lee IM, Hsieh CC, Paffenbarger RS Jr Exercise intensity and longevity in men. The Harvard Alumni Health Study. JAMA. 1995 Apr 19;273(15):1179-84.
Lippi G, Maffulli N Biological influence of physical exercise on hemostasis. Semin Thromb Hemost. 2009 Apr;35(3):269-76. doi: 10.1055/s-0029-1222605. Epub 2009 May 18. Review.
Macfarlane DJ, Lee CC, Ho EY, Chan KL, Chan D Convergent validity of six methods to assess physical activity in daily life. J Appl Physiol (1985). 2006 Nov;101(5):1328-34. Epub 2006 Jul 6.
Zourikian N, Merlen C, Bonnefoy A, St-Louis J, Rivard GE Effects of moderate-intensity physical exercise on pharmacokinetics of factor VIII and von Willebrand factor in young adults with severe haemophilia A: a pilot study. Haemophilia. 2016 May;22(3):e177-83. doi: 10.1111/hae.12869. Epub 2016 Mar 14.
PHYSICAL ACTIVITY AND FVIII CLEARANCE: RELEVANCE FOR PERSONALIZED THERAPY IN SEVERE HAEMOPHILIA A
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
